These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7440567)

  • 21. The rapid desensitization of glucagon-stimulated adenylate cyclase is a cyclic AMP-independent process that can be mimicked by hormones which stimulate inositol phospholipid metabolism.
    Murphy GJ; Hruby VJ; Trivedi D; Wakelam MJ; Houslay MD
    Biochem J; 1987 Apr; 243(1):39-46. PubMed ID: 3038085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N alpha-Malto-glucagon and N alpha-malto, S-methyl methionine27-glucagon: preparation and characterization of two partial agonists.
    Coolican SA; Gurd RS
    Arch Biochem Biophys; 1984 Aug; 232(2):450-7. PubMed ID: 6380408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucagon carboxyl-terminal derivatives: preparation, purification, and characterization.
    England RD; Jones BN; Flanders KC; Coolican SA; Rothgeb TM; Gurd RS
    Biochemistry; 1982 Mar; 21(5):940-50. PubMed ID: 7074063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucagon antagonists: contribution to binding and activity of the amino-terminal sequence 1-5, position 12, and the putative alpha-helical segment 19-27.
    Unson CG; Gurzenda EM; Iwasa K; Merrifield RB
    J Biol Chem; 1989 Jan; 264(2):789-94. PubMed ID: 2536024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and properties of glucagon analogs prepared by semi-synthesis from CNBr-glucagon.
    Wright DE; Hruby VJ; Rodbell M
    Biochim Biophys Acta; 1980 Aug; 631(1):49-58. PubMed ID: 6249392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative efficacy of seven synthetic glucagon analogs, modified in position 1, 2 and/or 12, on liver and heart adenylate cyclase from rat.
    Robberecht P; Waelbroeck M; Camus JC; De Neef P; Coy DH; Christophe J
    Peptides; 1986; 7 Suppl 1():109-12. PubMed ID: 3018688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural requirements for glucagon receptor binding and activation of adenylate cyclase in liver. Study of chemically modified forms of the hormone, including N alpha-trinitrophenyl glucagon, an antagonist.
    Epand RM; Rosselin G; Hoa DH; Cote TE; Laburthe M
    J Biol Chem; 1981 Feb; 256(3):1128-32. PubMed ID: 6256384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylation of glucagon, characterization of the sulfonium derivative, and regeneration of the native covalent structure.
    Rothgeb TM; Jones BN; Hayes DF; Gurd RS
    Biochemistry; 1977 Dec; 16(26):5813-8. PubMed ID: 588556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-function studies on positions 17, 18, and 21 replacement analogues of glucagon: the importance of charged residues and salt bridges in glucagon biological activity.
    Sturm NS; Lin Y; Burley SK; Krstenansky JL; Ahn JM; Azizeh BY; Trivedi D; Hruby VJ
    J Med Chem; 1998 Jul; 41(15):2693-700. PubMed ID: 9667960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthetic linear and cyclic glucagon antagonists.
    Dharanipragada R; Trivedi D; Bannister A; Siegel M; Tourwe D; Mollova N; Schram K; Hruby VJ
    Int J Pept Protein Res; 1993 Jul; 42(1):68-77. PubMed ID: 8396562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptor occupancy and adenylate cyclase activation in rat liver and heart membranes by 10 glucagon analogs modified in position 2,3, 4, 25, 27 and/or 29.
    Robberect P; Damien C; Moroder L; Coy DH; Wünsch E; Christophe J
    Regul Pept; 1988 May; 21(1-2):117-28. PubMed ID: 2839870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acetylglucagon: preparation and characterization.
    Desbuguois B
    Eur J Biochem; 1975 Dec; 60(2):335-47. PubMed ID: 1270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucagon: structure-function relationships investigated by sequence deletions.
    Frandsen EK; Grønvald FC; Heding LG; Johansen NL; Lundt BF; Moody AJ; Markussen J; Vølund A
    Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):665-77. PubMed ID: 6268519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [12-Homoarginine]glucagon: synthesis and observations on conformation, biological activity, and copper-mediated peptide cleavage.
    Ross JB; Rousslang KW; de Haën C; Lavis VR; Deranleau DA
    Biochim Biophys Acta; 1979 Feb; 576(2):372-84. PubMed ID: 427194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipolytic and adenyl-cyclase-stimulating activity of N alpha-trinitrophenyl glucagon: comparison with other glucagon derivatives modified at the amino terminus.
    Jean-Baptiste E; Rizack MA; Epand RM
    Biosci Rep; 1982 Mar; 2(3):163-7. PubMed ID: 7066487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of potent glucagon antagonists: structure-activity relationship study of glycine at position 4.
    Ahn JM; Medeiros M; Trivedi D; Hruby VJ
    J Pept Res; 2001 Aug; 58(2):151-8. PubMed ID: 11532074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of [1-N alpha-trinitrophenylhistidine, 12-homoarginine]glucagon on cyclic AMP levels and free fatty acid release in isolated rat adipocytes.
    García-Sáinz JA; Sánchez-Sevilla L; Pelton JT; Trivedi D; Hruby VJ
    Biochim Biophys Acta; 1986 Apr; 886(2):310-5. PubMed ID: 3008855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormonal regulation of Gi2 alpha-subunit phosphorylation in intact hepatocytes.
    Bushfield M; Murphy GJ; Lavan BE; Parker PJ; Hruby VJ; Milligan G; Houslay MD
    Biochem J; 1990 Jun; 268(2):449-57. PubMed ID: 2114093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new approach to search for the bioactive conformation of glucagon: positional cyclization scanning.
    Ahn JM; Gitu PM; Medeiros M; Swift JR; Trivedi D; Hruby VJ
    J Med Chem; 2001 Sep; 44(19):3109-16. PubMed ID: 11543679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-function studies of analogues of parathyroid hormone (PTH)-1-34 containing beta-amino acid residues in positions 11-13.
    Peggion E; Mammi S; Schievano E; Silvestri L; Schiebler L; Bisello A; Rosenblatt M; Chorev M
    Biochemistry; 2002 Jun; 41(25):8162-75. PubMed ID: 12069609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.